Individual fertility assessment and pro-fertility counselling; Should this be offered to women and men of reproductive age?

Human Reproduction

Volumn 30, Issue 1, 2015, Pages 9-15

  Hvidman, Helene W ^a   Petersen, Kathrine Birch ^a   Larsen, Elisabeth C ^a   Macklon, Kirsten Tryde ^a   Pinborg, Anja ^b   Andersen, Anders Nyboe ^a  

^a Rigshospitalet   (Denmark)

^b Mental Health Services CPH   (Denmark)

Author keywords

anti Mullerian hormone; family planning; prediction fertility; reproductive lifespan; reproductive risk

Indexed keywords

MUELLERIAN INHIBITING FACTOR;

ADULT; CLINICAL ASSESSMENT; CONTRACEPTION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FAMILY ATTITUDE; FAMILY COUNSELING; FAMILY PLANNING; FAMILY SIZE; FEMALE; FEMALE FERTILITY; FERTILITY ASSESSMENT AND COUNSELLING; GYNECOLOGICAL EXAMINATION; HEALTH CARE FACILITY; HEALTH PROGRAM; HIGH RISK PREGNANCY; HOSPITAL CARE; HUMAN; LIFESPAN; MALE; MALE FERTILITY; MALE INFERTILITY; MASS SCREENING; MIDDLE AGED; OVARIAN RESERVE; OVULATION PREDICTION; PELVIS; POPULATION; PREGNANCY; REPRODUCTION; REPRODUCTIVE HEALTH; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEMEN ANALYSIS; TRANSVAGINAL ECHOGRAPHY; YOUNG ADULT; AGE; BLOOD; COUNSELING; FERTILITY; PROCEDURES;

ADULT; AGE FACTORS; ANTI-MULLERIAN HORMONE; COUNSELING; FAMILY PLANNING SERVICES; FEMALE; FERTILITY; HUMANS; MALE; OVARIAN RESERVE; RISK FACTORS; SEMEN ANALYSIS;

EID: 84922444447     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu305     Document Type: Review

References (42)

1. Alkema L, Kantorova V, Menozzi C, Biddlecom A. National, regional, and global rates and trends in contraceptive prevalence and unmet need for family planning between 1990 and 2015: a systematic and comprehensive analysis. Lancet 2013;381:1642-1652.
2. Bavan B, Porzig E, Baker VL. An assessment of female university students attitudes towards screening technologies for ovarian reserve. Fertil Steril 2011;96:1195-1199.
3. Bentzen JG, Forman JL, Pinborg A, Lidegaard , Larsen EC, Friis-Hansen L, Johannsen TH, Nyboe Andersen A. Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception. Reprod Biomed Online 2012;25:612-619.
4. Bentzen JG, Forman JL, Larsen EC, Pinborg A, Johannsen TH, Schmidt L, Friis-Hansen L, Nyboe Andersen A. Maternal menopause as a predictor of anti-Müllerian hormone level and antral follicle count in daughters during reproductive age. Hum Reprod 2013;28:247-255.
5. Benzies KM. Advanced maternal age: are decisions about the timing of child-bearing a failure to understand the risks? CMAJ 2008;178:183-184.
6. Bonde JP, Ernst E, Jensen TK, Hjollund NH, Kolstad H, Hendriksen TB, Scheike T, Givercman A, Olsen J, Skakkebæk NE. Relation between semen quality and fertility: a population-based study of 430 first-pregnancy planners. Lancet 1998;352:1172-1177.
7. Bonde JP, Hjollund HN, Kolstad HA, Abell A, Larsen SB. Environmental semen studies-is infertility increased by a decline in sperm count? Scand JWork Environ Health 1999;25(Suppl 1):12-16.
8. Bretherick KL, Fairbrother N, Avila L, Harbord SH, Robinson WP. Fertility and aging: do reproductive-age Canadian women know what they need to know? Fertil Steril 2010;93:2162-2168.
9. Broer SL, Eijkemans MJ, Scheffer GJ, van Rooij IA, de Vet A, Themmen AP, Laven JS, de Jong FH, Te Velde ER, Fauser BC et al. Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab 2011;96:2532-2539.
10. Broer SL, Broekmans FJ, Laven JS, Fauser BC. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update 2014;20:688-701.
11. Buck Louis GM, Sundaram R, Schisterman EF, Sweeney A, Lynch CD, Kim S, Maisog JM, Gore-Langton R, Eisenberg ML, Chen Z. Semen quality and time to pregnancy: the longitudinal investigation of fertility and the environment study. Fertil Steril 2014;101:453-462.
12. Bunting L, Boivin J. Development and preliminary validation of the fertility status awareness tool: FertiSTAT. Hum Reprod 2010;25:1722-1733.
13. Dolleman M, Depmann M, Eijkemans MJ, Heimensem J, Broer SL, van der Stroom EM, Laven JS, Van Rooij IA, Scheffer GJ, Peeters PH et al. Anti-Mullerian hormone is a more accurate predictor of individual time to menopause than mothers age at menopause. Hum Reprod 2014; 29:584-591.
14. Frederiksen ME, Tjrnhj-Thomsen T, Schmidt L. Solo mother by donor-the plan B of motherhood. A perspective on person-centered reproductive medicine. Int J Pers Cent Med 2011;1:800-807.
15. Freeman EW, Sammel MD, Lin H, Gracia CR. Anti-Mullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab 2012;97:1673-1680.
16. Hagen CP, Juul A, Skakkebæk NE, Andersson AM, Main KM, Hjllund NH, Ernst E, Bonde JP, Anderson RA, Jensen TK. Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study. Fertil Steril 2012;98:1602-1608.
17. Hammarberg K, Setter T, Norman RJ, Holden CA, Michelmore J, Johnson L. Knowledge about factors that influence fertility among Australians of reproductive age: a population-based study. Fertil Steril 2013;99:502-507.
18. Jadva V, Badger S, Morrissette M, Golombok S. Mom by choice, single by lifes circumstance... Findings from a large scale survey of the experiences of single mothers by choice. Hum Fertil 2009;12:175-184.
19. Lampic C, Svanberg AS, Karlstrom P, Tyden T. Fertility awareness, intentions concerning childbearing, and attitudes towards parenthood among female and male academics. Hum Reprod 2006;21:558-564.
20. Larsen L, Scheike T, Kold Jensen T, Bonde JP, Ernst E, Hjollund NH, Zhou Y, Skakkebæk NE, Givercman A and The Danish First Pregnancy Planner Study Team. Computer-assisted semen analysis parameters as predictors of fertility of men from the general population. Hum Reprod 2000;15:1562-1567.
21. Leridon H. Demographic effects of the introduction of steroid contraception in developed countries. Hum Reprod Update 2006;12:603-616.
22. Leridon H, Slama R. The impact of a decline in fecundity and of pregnancy postponement on final number of children and demand for assisted reproductive technology. Hum Reprod 2008;23:1312-1319.
23. LockwoodGM. Social egg freezing: the prospect of reproductive immortality or a dangerous delusion? Reprod Biomed Online 2011;23:334-340.
24. Lutz W, Kc S. Global human capital: integrating education and population. Science 2011;333:587-592.
25. Mertes H, Pennings G. Social egg freezing: for better, not for worse. Reprod Biomed Online 2011;23:824-829.
26. Mills M, Rindfuss RR, McDonaldd P, teVelde E. Why do people postpone parenthood? Reasons and social policy incentives. Hum Reprod Update 2011;17:848-860.
27. Molloy D, Hall BA, Ilbery M, Irving J, Harrison KL. Oocyte freezing: timely reproductive insurance? Med J Aust 2009;190:247-249.
28. Mortensen L, Hegaard HK, Nyboe Andersen A, Bentzen JG. Attitudes towards motherhood and fertility awareness among 20-40-year-old female healthcare professionals. Eur J Contracept Reprod Health Care 2012;17:468-481.
29. Peterson BD, Pirritano M, Tucker L, Lampic C. Fertility awareness and parenting attitudes among American male and female undergraduate university students. Hum Reprod 2012;27:1375-1382.
30. Rienzi L, Cobo A, Paffoni A, Scarduelli C, Capalbo A, Vajta G, Remohi J, Ragni G, Ubaldi FM. Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study. Hum Reprod 2012;27:1606-1612.
31. Schmidt L, Sobotka T, Bentzen JG, Nyboe Andersen A. On behalf of the ESHRE Reproduction and Society Task Force. Demographic and medical consequences of the postponement of parenthood. Hum Reprod Update 2012;18:29-43.
32. Steiner AZ, Herring AH, Kesner JS, Meadows JW, Stanczyk FZ, Hoberman S, Baird DD. Antimullerian hormone as a predictor of natural fecundability in women aged 30-42 years. Obstet Gynecol 2011; 117:798-804.
33. Stern J, Larsson M, Kristiansson P, Tyden T. Introducing reproductive life plan-based information in contraceptive counselling: an RCT. Hum Reprod 2013;28:2450-2461.
34. Stoop D, Nekkebroeck J, Devroey P.Asurveyon the intentions and attitudes towards oocyte cryopreservation for non-medical reasons among women of reproductive age. Hum Reprod 2011;26:655-661.
35. Tehrani FR, Solaymani-Dodaran M, Tohidi M, Gohari MR, Azizi F. Modeling age at menopause using serum concentration of anti-Mullerian hormone. J Clin Endocrinol Metab 2013;98:729-735.
36. Tehrani FR, Dolleman M, van Disseldorp J, Broer SL, Azizi F, Solaymani-Dodaran M, Fauser BC, Laven JSE, Eijkemans MJC, Broekmans F. Predicting menopausal age with anti-Mullerian hormone: a cross-validation study of two existing models. Climacteric 2014;17:1-8.
37. te Velde ER
38. United Nations. Report of the International Conference on Population and Development. New York: United Nations, 1995, pp. 40-41.
39. Wojcieszek AM, Thompson R. Conceiving of change: a brief intervention increases young adults knowledge of fertility and the effectiveness of in vitro fertilization. Fertil Steril 2013;100:523-529.
40. Wyndham N, Figueira P, Patrizio P. A persistent misperception: assisted reproductive technology can reverse the aged biological clock. Fertil Steril 2012;97:1044-1047.
41. Yarde F, Voorhuis M, Dolleman M, Knauff EA, Eijkemans MJ, Broekmans FJ. Antimüllerian hormone as predictor of reproductive outcome in subfertile women with elevated basal follicle-stimulating hormone levels: a follow-up study. Fertil Steril 2013;100:831-838.
42. Zinaman MJ, Brown CC, Selevan SG, Clegg ED. Semen quality and human fertility: a prospective study with healthy couples. J Androl 2000;21: 145-153.